Skip and go to content
solutions@vitroscan.nl
Home
Biopharma
Open Biopharma
Services
Technology
Resources
Contact
Patients & Doctors
Open Patients & Doctors
Solutions for cancer patients
How does it work
Clinical trial program
Resources
Contact
Company
Open Company
VitroScan Story
VitroScan Team
Careers
Contact
News & Events
Open News & Events
News
Events
Menu
Menu
Home
Biopharma
Patients & Doctors
Company
News & Events
Back
to Biopharma
Biopharma
Services
Technology
Resources
Contact
Back
to Resources
Resources
Posters
Back
to Patients & Doctors
Patients & Doctors
Solutions for cancer patients
How does it work
Clinical trial program
Resources
Contact
Back
to Company
Company
VitroScan Story
VitroScan Team
Careers
Contact
Back
to News & Events
News & Events
News
Events
solutions@vitroscan.nl
Posters
Ex vivo tumor testing platform for predicting clinical response to platinum-based therapy in high grade serous ovarian cancer patients
Basket trial for chemotherapy response prediction for lung, bladder, and ovarian cancer patients
Absence of synergistic effects for PARPi and immunotherapy combinations in ex vivo 3D tumor testing for ovarian cancer patients
Ex vivo micro tumor testing to assess patient-specific sensitivity to targeted therapies
Ex vivo 3D tumor testing enables NSCLC patient stratification for chemo-, immuno-, and targeted therapy
Chemotherapy sensitivity score based on ex vivo 3D tumor testing to predict clinical response for ovarian cancer patients
EVITA trial for ex vivo drug sensitivity testing in urothelial cancer
Interpretation of patient-specific ex vivo immunotherapy response for ovarian cancer
Ex-vivo 3D functional assay enables patient-specific immunotherapy response classification
Home
Biopharma
Resources
Posters